![peter vlasselaer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
peter vlasselaer
Directeur/Membre du Conseil chez Inspirna, Inc.
Provenance du réseau au premier degré de peter vlasselaer
Entité | Type d'entité | Industrie | |
---|---|---|---|
Stanford University
328
| College/University | Other Consumer Services | 328 |
SR One Capital Management LP
![]() SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California.
18
| Private Company | Investment Managers | 18 |
NanoDimension Management Ltd.
![]() NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town.
17
| Private Company | Investment Managers | 17 |
Inspirna, Inc.
![]() Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Amphivena Therapeutics, Inc.
![]() Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.
10
| Holding Company | Drugstore Chains | 10 |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.
6
| Subsidiary | Biotechnology | 6 |
Comet Therapeutics, Inc.
![]() Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Blade Therapeutics, Inc.
![]() Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à peter vlasselaer via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Consultant / Advisor President | |
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
CoTherix, Inc.
![]() CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
IlluminOss Medical, Inc.
![]() IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Medical Specialties | Director/Board Member Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Operating Officer | |
Brown University | College/University | Undergraduate Degree Corporate Officer/Principal | |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Chief Executive Officer Private Equity Investor Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor Corporate Officer/Principal Private Equity Investor General Counsel Director/Board Member Comptroller/Controller/Auditor | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Chairman Private Equity Investor | |
University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
Yale University | College/University | Undergraduate Degree Graduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Swiss Federal Institute of Technology | College/University | President Graduate Degree Director/Board Member | |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Second Genome, Inc.
![]() Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Auxogyn, Inc.
![]() Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Director/Board Member Private Equity Investor President | |
ZappRx, Inc.
![]() ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ARCELLX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Pandion Operations, Inc.
![]() Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Qiming US Ventures Management, LLC
![]() Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Simcha Therapeutics Holding Co. LLC
![]() Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Chairman | |
HotSpot Therapeutics, Inc.
![]() HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Simcha Therapeutics, Inc.
![]() Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Dren Bio, Inc.
![]() Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
MiroBio Ltd.
![]() MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman | |
PANDION THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
F-star Therapeutics Ltd.
![]() F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ICOSAVAX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiques
Internationale
Etats-Unis | 41 |
Royaume-Uni | 5 |
Suisse | 4 |
France | 2 |
Israël | 2 |
Sectorielle
Health Technology | 26 |
Consumer Services | 16 |
Finance | 6 |
Commercial Services | 5 |
Opérationnelle
Director/Board Member | 552 |
Corporate Officer/Principal | 207 |
Independent Dir/Board Member | 94 |
Private Equity Investor | 92 |
Chairman | 80 |
Relations les plus connectées
Insiders | |
---|---|
Antoine Papiernik | 48 |
Tzar Kuoi Li | 44 |
Luke Evnin | 42 |
Eric Rowinsky | 36 |
Patrick Aebischer | 35 |
Mark McDade | 35 |
Andrew R. Garman | 34 |
Dieter Weinand | 32 |
Nancy T. Chang | 31 |
Raj Atluru | 30 |
Roel Bulthuis | 29 |
Deborah Harland | 27 |
Nilesh Kumar | 26 |
Rajeev Dadoo | 24 |
Jake Bauer | 24 |
- Bourse
- Insiders
- peter vlasselaer
- Connexions Sociétés